【来源：川观新闻】刘梦 川观新闻记者 任紫鑫 近日，国产铽-161标记核素药物在绵阳完成第一例给药。 这款药物由绵阳市中心医院、中国工程物理研究院核物理与化学研究所及某医药科技有限公司，基于国产新兴治疗医用核素铽（161Tb）的前列腺特异性膜抗原（Prostate Specific Membrane ...

Discover a study where results from the 2,129 participants revealed that Stockholm3 demonstrated non-inferior sensitivity ...

Primarily used to screen for prostate cancer, PSA tests measure the level of prostate-specific antigen in the blood. “The ...

The following is a summary of “A cross-sectional study of the association between depression and serum prostate-specific ...

Researchers at UCLA have unveiled startling findings using PSMA-PET imaging that reveal nearly half of patients diagnosed ...

There are several strategies for the early detection of prostate cancer. The first step is often a blood test for ...

Prostate cancer ranks among the most common health challenges men face worldwide. While medical advances continue to improve treatment outcomes, the e ...

A study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk ...

Prostate cancer stands as one of the most prevalent cancers affecting men worldwide. Each year, millions of men and their ...

Greater investments in ongoing clinical trials and oncology research encourage innovation in the treatment, thus boosting the ...

Mr Hearn, president of the Professional Darts Corporation (PDC), said an awareness campaign about the disease had given him ...

Tech advancements are helping patients recover more quickly and comfortably, with less pain and shorter hospital stays.